Orthopediatrics (KIDS) Shares Outstanding (Diluted Average) (2019 - 2026)

Orthopediatrics' Shares Outstanding (Diluted Average) history runs 8 years deep, the most recent figure standing at $23.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) rose 1.96% year-over-year to $23.7 million; the TTM figure through Mar 2026 stood at $23.7 million (up 1.96% YoY), while the FY2025 annual figure was $23.5 million, up 1.65% from the prior year.
• Shares Outstanding (Diluted Average) was $23.7 million for Q1 2026 at Orthopediatrics, up from $23.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $23.7 million in Q1 2026 to a low of $19.4 million in Q1 2022.
• Historically, Shares Outstanding (Diluted Average) has averaged $22.4 million across 5 years, with a median of $22.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Diluted Average) grew 0.87% in 2022, then grew 16.21% in 2023.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $20.9 million in 2022, then rose by 8.25% to $22.7 million in 2023, then grew by 1.77% to $23.1 million in 2024, then increased by 1.65% to $23.5 million in 2025, then grew by 0.96% to $23.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $23.7 million (Q1 2026), $23.5 million (Q4 2025), and $23.6 million (Q3 2025), per Business Quant data.